DE60207848D1 - Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung - Google Patents

Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung

Info

Publication number
DE60207848D1
DE60207848D1 DE60207848T DE60207848T DE60207848D1 DE 60207848 D1 DE60207848 D1 DE 60207848D1 DE 60207848 T DE60207848 T DE 60207848T DE 60207848 T DE60207848 T DE 60207848T DE 60207848 D1 DE60207848 D1 DE 60207848D1
Authority
DE
Germany
Prior art keywords
therapeutic use
production
human immunoglobulins
concentrated human
concentrated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60207848T
Other languages
English (en)
Other versions
DE60207848T2 (de
Inventor
Sami Chtourou
Philippe Paolantonacci
Roland Schmitthaeusler
Jacky Lirochon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LFB SA filed Critical LFB SA
Publication of DE60207848D1 publication Critical patent/DE60207848D1/de
Application granted granted Critical
Publication of DE60207848T2 publication Critical patent/DE60207848T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60207848T 2001-05-11 2002-04-24 Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung Expired - Lifetime DE60207848T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0106234 2001-05-11
FR0106234A FR2824568B1 (fr) 2001-05-11 2001-05-11 Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
PCT/FR2002/001407 WO2002092632A1 (fr) 2001-05-11 2002-04-24 Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique

Publications (2)

Publication Number Publication Date
DE60207848D1 true DE60207848D1 (de) 2006-01-12
DE60207848T2 DE60207848T2 (de) 2006-08-17

Family

ID=8863163

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60207848T Expired - Lifetime DE60207848T2 (de) 2001-05-11 2002-04-24 Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung

Country Status (11)

Country Link
US (1) US7186410B2 (de)
EP (1) EP1385886B1 (de)
JP (1) JP4445202B2 (de)
AT (1) ATE312120T1 (de)
CA (1) CA2446704C (de)
DE (1) DE60207848T2 (de)
DK (1) DK1385886T3 (de)
ES (1) ES2254676T3 (de)
FR (1) FR2824568B1 (de)
IL (2) IL158893A0 (de)
WO (1) WO2002092632A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
PT1981540E (pt) * 2006-01-30 2013-05-07 Grifols Therapeutics Inc Método de tratamento e profilaxia de doenças relacionadas com a deposição de amilóides utilizando igm
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
FR2899112B1 (fr) 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines et de fragments f (ab)'2 et/ou fab specifiques d'un arbovirus en tant que medicament.
US8119104B2 (en) * 2006-12-13 2012-02-21 Michael R. Simon Treatment of celiac disease with IgA
US7597891B2 (en) * 2006-12-13 2009-10-06 Simon Michael R Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
US7794721B2 (en) * 2006-12-13 2010-09-14 Simon Michael R Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
FR2939667B1 (fr) 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
FR2940617B1 (fr) 2008-12-30 2012-04-20 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobulines g
EP3708581A3 (de) 2009-05-27 2021-10-20 Takeda Pharmaceutical Company Limited Verfahren zur herstellung eines hochkonzentrierten immunglobulinpräparats zur subkutanen verwendung
FR2949195B1 (fr) 2009-08-24 2011-10-14 Lfb Biomedicaments Poche de stockage de solution therapeutique
US8304248B2 (en) 2009-11-16 2012-11-06 Torres Anthony R Protein separation via ion-exchange chromatography and associated methods, systems, and devices
FR2952826B1 (fr) 2009-11-20 2012-04-06 Lab Francais Du Fractionnement Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
FR2961107B1 (fr) 2010-06-15 2012-07-27 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines stabilisee
FR2962650B1 (fr) * 2010-07-19 2013-04-05 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines concentrees
FR2974301B1 (fr) * 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
FR2977893B1 (fr) 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
CN110343171A (zh) 2012-02-29 2019-10-18 百深公司 周围神经的IgG刺激髓鞘再生
SG11201404958SA (en) 2012-03-09 2014-11-27 Csl Behring Ag Compositions comprising secretory - like immunoglobulins
EP2636684A1 (de) 2012-03-09 2013-09-11 CSL Behring AG Vorbeugung von Infektionen
EP2636681A1 (de) * 2012-03-09 2013-09-11 CSL Behring AG Verfahren zur Anreicherung von IgA
KR20150123796A (ko) * 2013-02-28 2015-11-04 에이전시 포 사이언스, 테크놀로지 앤드 리서치 크로마틴 결핍 세포 배양 수확물로부터의 항체들의 크로마토그래프 정제
PT2969099T (pt) * 2013-03-14 2018-07-05 Amgen Inc Remoção de ligandos escapados de cromatografia de afinidade
KR20160012975A (ko) * 2013-06-04 2016-02-03 에이전시 포 사이언스, 테크놀로지 앤드 리서치 단백질 정제 프로세스
CN105358228A (zh) * 2013-07-05 2016-02-24 法国血液分割暨生化制品实验室 亲和层析基质
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
FR3035971A1 (fr) 2015-05-07 2016-11-11 Lab Francais Du Fractionnement Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b
CN105126100B (zh) * 2015-09-23 2021-01-26 成都蓉生药业有限责任公司 一种富含IgM的人免疫球蛋白制剂及其制备方法
EP3275897A1 (de) * 2016-07-27 2018-01-31 Biotest AG Verfahren zur herstellung von immunoglobulinzusammensetzungen
FR3064485A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Traitement d'une infection par le virus respiratoire syncytial
FR3064486A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures
FR3064484A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition d'immunoglobulines utiles pour traiter des infections virales
CN108101981B (zh) * 2018-01-15 2019-06-04 四川远大蜀阳药业有限责任公司 一种静注免疫球蛋白的生产工艺
FR3081328B1 (fr) 2018-05-24 2021-01-01 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines concentrees
MX2022011950A (es) 2020-03-31 2022-10-21 Takeda Pharmaceuticals Co Metodo para producir una preparacion de inmunoglobulina a partir de plasma con reduccion del inhibidor de c-1.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305870A (en) * 1979-01-31 1981-12-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Intravenous plasma derivatives and their production
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
DE3927112C1 (de) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
DE59009020D1 (de) * 1990-03-22 1995-06-08 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
FR2706466B1 (fr) * 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6150507A (en) * 1995-03-23 2000-11-21 Biopure Corporation Method for producing a purified hemoglobin product
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
JP4359352B2 (ja) * 1997-10-23 2009-11-04 田辺三菱製薬株式会社 室温保存製剤
CA2330170C (en) 1998-06-09 2010-11-02 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Also Published As

Publication number Publication date
JP4445202B2 (ja) 2010-04-07
ATE312120T1 (de) 2005-12-15
US20040132979A1 (en) 2004-07-08
FR2824568A1 (fr) 2002-11-15
EP1385886B1 (de) 2005-12-07
JP2005500265A (ja) 2005-01-06
EP1385886A1 (de) 2004-02-04
IL158893A (en) 2009-08-03
CA2446704C (fr) 2013-09-24
WO2002092632A1 (fr) 2002-11-21
ES2254676T3 (es) 2006-06-16
FR2824568B1 (fr) 2004-04-09
AU2002257887A2 (en) 2002-11-25
DK1385886T3 (da) 2006-04-18
US7186410B2 (en) 2007-03-06
IL158893A0 (en) 2004-05-12
CA2446704A1 (fr) 2002-11-21
DE60207848T2 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
DE60207848D1 (de) Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung
DE60201496D1 (de) Verfahren zur konzentrierung von unlöslichen protein mittels filtration mit schwingenden membranen
DE602005009856D1 (de) Verfahren zur reinigung von fsh
WO2003102132A3 (en) Non-affinity purification of proteins
ATE316860T1 (de) Verfahren zur automatischen herstellung von brillenlinsen
DE69834533D1 (de) Verfahren zur Protein-Herstellung
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DK1329462T3 (da) Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin
DE69628421D1 (de) Verfahren zur herstellung von tetraazacycloalkanen.
DE69700843T2 (de) Verfahren zur reinigung opazifierender kontrastmittel
DE60027932D1 (de) Verfahren zur herstellung von proteinhydrolysaten
DE59607103D1 (de) Verfahren zur gewinnung von 2-hydroxy-4-methylthiobuttersäure (mha)
ATE194167T1 (de) Ein prozess für die herstellung von faktor ix biologischen ursprungs
DE69610421D1 (de) Verfahren zur herstellung von alpha,beta-ungesättigten nitrilen
DE69618481T2 (de) Verfahren zur herstellung von halogenkohlenwasserstoffen
DE69811677T2 (de) Verfahren zur präparation von enantiomer-angereicherten, n-derivatisierten laktamen.
DE59807664D1 (de) Verfahren zur herstellung von 3-cyano-2,4-dihalogen-5-fluor-benzoesäuren
DE69613309D1 (de) Verfahren zur Abtrennung von Cyclohexen
ATE338750T1 (de) Verfahren zur herstellung von chinolinderivaten
DE59605320D1 (de) Verfahren zur herstellung von 4-cyano-2,5-difluoranilin
ATE185790T1 (de) Verfahren zur herstellung von alpha,omega- bromochloroalkanen
DE50203529D1 (de) Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte
DE69616343D1 (de) Verfahren zur herstellung von isochromanverbindungen.
ATE282026T1 (de) Verfahren zur herstellung von halo-4-phenoxy- chinolinen
DE69604676T2 (de) Verfahren zur herstellung von alpha, omega-bromochloroalkanen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition